Qubit Pharmaceuticals, a deeptech company specialising in molecular simulation and modelling using quantum physics, has raised €16.1 million from XAnge, Omnes, Quantonation and Octave Klaba, founder of OVH.
This seed round with investors specialised in Life Sciences and Deep Tech brings the total amount raised since the company’s creation in 2020 to more than €23 million.
The transaction aims at strengthening Qubit Pharmaceutical’s proprietary Atlas software platform, capable of leveraging the computing power of supercomputers and quantum computers to accelerate the development of more effective and safer drug candidates.
